Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disorder worldwide, with an increasing incidence driven by the global rise in obesity and metabolic syndrome
Turkevich J, Stevenson PC, Hillier J
You might have heard that starchy carbohydrates are off-limits, or perhaps you are worried that your favorite side dish will trigger the nausea often associated with these treatments
You can explore treatment options at Check Your Eligibility If you want to learn whether GLP-1 treatment is right for you and receive personalized guidance from providers who understand the complexities of real-world treatment (including practical questions about alcohol and lifestyle), you can start by completing Mochi's eligibility questionnaire
That said, some patients using Wegovy report changes in their sleep patterns, either as a side effect of the medication itself or as a consequence of dietary changes and weight loss